Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Targeted therapy focuses on particular cancer-related targets or processes, chemotherapy acts on fast-growing cells, and immunotherapy helps the immune system fight cancer. They are not interchangeable treatments, and none is always the safest or most effective. A tumor’s features, cancer type and stage, the patient’s health, and the available treatment options all shape the choice. Some treatments also overlap or are used together.
How does targeted cancer therapy compare with chemotherapy and immunotherapy?
The main difference is what each approach acts on. Chemotherapy can affect cancer cells because they grow and divide quickly, but it can also affect healthy fast-growing cells. Targeted therapy acts on particular proteins or other processes that help cancer cells grow, divide, or spread. Immunotherapy works through the immune system, helping it recognize or attack cancer.
As an Amazon Associate I earn from qualifying purchases.
Those descriptions explain the broad mechanisms, not a ranking. A treatment’s usefulness depends on whether it fits the particular cancer and the patient’s situation. Targeted therapy often depends on finding a relevant tumor target; a biomarker match may help identify a treatment option but does not guarantee that it will work. Side effects differ by treatment and person, so the names of the categories alone cannot predict which option will be easiest to tolerate.
Free tools Windows power users keep installed
One-click scans. No signup required.
| Approach | What it acts on | How selection may work | Important limitation |
|---|---|---|---|
| Chemotherapy | Fast-growing cells, including cancer cells; healthy fast-growing cells can also be affected. | Depends on cancer type and extent, among other treatment-planning factors. | Effects on healthy cells can cause side effects; the specific effects depend on the treatment. |
| Targeted therapy | Particular proteins or processes that help cancer cells grow, divide, and spread. | Tumor testing may be used to see whether a treatment-relevant target is present. | A target result does not ensure response, and cancer cells may become resistant. |
| Immunotherapy | The immune system’s ability to fight cancer. | Biomarker testing can identify features that may support certain immunotherapies. | Immune activity can affect healthy tissues and cause inflammation-related side effects. |
The National Cancer Institute (NCI) describes these approaches as parts of a broader treatment landscape: chemotherapy may be used alone or with other treatments, and many monoclonal antibodies are targeted therapies, while some also count as immunotherapy. NCI’s overview of cancer treatment explains that options depend on the cancer and its circumstances.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
In practical terms, the comparison has several separate parts. The mechanism tells you how a treatment is intended to work. Biomarker testing may help determine whether some targeted therapies or immunotherapies are options. Side-effect mechanisms can differ, but the treatment category does not establish the exact effects or their severity. Finally, the cancer’s type and extent, the patient’s circumstances, and the plan’s goals affect how clinicians use any of these approaches.
What chemotherapy does
Chemotherapy uses drugs to stop or slow the growth of cancer cells. Because many cancer cells grow and divide quickly, these drugs can affect them. But some healthy cells also grow quickly. The NCI identifies cells in the mouth and intestines and cells involved in hair growth among the healthy cells chemotherapy can harm, which helps explain why side effects can occur. See NCI’s patient guide, Chemotherapy and You.
The purpose of chemotherapy varies with the cancer type and how extensive it is. It may be used to cure cancer, control it, or ease symptoms. It can be given on its own, but may also be part of a plan that includes surgery, radiation, targeted therapy, or immunotherapy. That means “chemotherapy versus another treatment” is not always the right framing: a clinician may consider more than one approach in the same overall plan.
The fast-growing-cell mechanism is useful to understand, but it does not predict every person’s side effects or say whether chemotherapy is appropriate. The particular drug, cancer, treatment plan, and individual health matter. The NCI guide describes chemotherapy and its effects; a patient’s oncology team can explain which effects are relevant to the proposed regimen.
When discussing chemotherapy, it can help to clarify its intended role in the overall plan. Ask whether the goal is to cure, control, or ease symptoms, and how the team will judge whether the treatment is helping. If chemotherapy is being considered alongside surgery, radiation, targeted therapy, or immunotherapy, ask what each component is intended to contribute. These questions apply to the specific plan; the broad label “chemotherapy” alone does not tell you its purpose or how it will be used.
What targeted therapy does—and why tumor testing may matter
Targeted therapy is designed to interfere with cancer-related proteins or other processes that help cancer cells grow, divide, and spread. Many such treatments interfere with particular proteins. Some block signals involved in growth or the formation of blood vessels that feed a tumor; other approaches deliver a cell-killing substance to cells carrying a specific target. The mechanism depends on the therapy. The NCI’s explanation is available in Targeted Therapy to Treat Cancer.
In many cases, a clinician needs information about the tumor to determine whether it has a target that a treatment can act on. Biomarker testing can look for features of a cancer that may help guide treatment selection. A test can therefore help answer an eligibility question: is there a feature that makes a particular targeted treatment—or, in some cases, an immunotherapy—worth considering? NCI explains the purpose and limits of this process in Biomarker Testing for Cancer Treatment.
A result is not a promise of benefit. Not every tumor cell necessarily has the same biomarkers, other cancer features can affect response, and there may be no available treatment that matches a result. Testing can identify a possible route, but it does not by itself establish that a drug will work for an individual. That distinction matters when interpreting a report: a detected feature is a piece of treatment-planning information, not a guarantee.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Targeted therapy is also not automatically mild or free of serious effects. The NCI lists diarrhea and liver problems among common effects, with fatigue, high blood pressure, skin changes, mouth sores, and other effects possible depending on the drug. Cancer cells can also become resistant to targeted therapy. Which effects and monitoring apply cannot be determined from the category name alone; the treatment-specific plan is essential.
Testing is a decision aid, not a treatment in itself. A result may make a therapy worth discussing, but the care team still needs to consider whether that option fits the cancer and the patient’s circumstances. Conversely, if a test does not identify a relevant feature—or no treatment is available for the feature found—that result does not settle the whole treatment decision. It is one part of the broader comparison with other available approaches.
Resistance is another reason a match should not be treated as a guarantee of lasting benefit. NCI notes that cancer cells can become resistant to targeted therapy. Ask the oncology team how it will assess whether a treatment is working and what alternatives might be considered if it is not. The answer will depend on the specific cancer and plan; there is no category-level timeline or outcome that applies to every targeted therapy.
What immunotherapy does
Immunotherapy helps the immune system fight cancer. Different immunotherapies can work in different ways. Some release immune “brakes” or otherwise increase immune activity; some antibodies mark cancer cells or bring immune cells close to them. The key contrast with chemotherapy is that immunotherapy works through immune activity rather than simply acting on fast-growing cells.
That mechanism creates a different side-effect concern: an activated immune system can affect healthy organs and tissues, causing inflammation-related effects. The type and dose of immunotherapy and the patient’s health and cancer can influence what happens. Side effects may arise during treatment or after it. NCI describes this variability in Immunotherapy Side Effects. Patients should ask their care team which symptoms need prompt attention and how to report them; a general description cannot substitute for instructions tied to the specific treatment.
Immunotherapy should not be understood as a single drug or a treatment with one predictable side-effect profile. The immune system’s role helps explain why effects can involve healthy tissues, but the relevant risks depend on the treatment and patient. Nor does the label mean that the therapy is suitable for every cancer: biomarker information may support use of certain immunotherapies, and the cancer context remains central.
For a proposed immunotherapy, ask specifically which symptoms call for prompt contact with the care team, including symptoms that arise after a treatment visit. The possibility of later effects is a reason to understand the treatment-specific instructions, not a reason to assume that every patient will develop inflammation or that all immunotherapies have identical risks. The care team can explain what to watch for with the particular treatment.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWhere the categories overlap
The three labels are useful for explaining mechanisms, but they are not perfectly separate boxes. NCI notes that many monoclonal antibodies are targeted cancer therapies, and some also qualify as immunotherapy because they help turn the immune system against cancer. In other words, one treatment can fit more than one mechanism-based description.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Combinations are also possible. Chemotherapy may be used with targeted therapy or immunotherapy, among other treatments. Whether to combine treatments is a clinical decision based on the cancer and the expected role of each treatment; the fact that a combination is possible does not mean it is appropriate for every patient. Ask the oncology team which part of a proposed plan is intended to do what, and whether the treatments are given together or in sequence.
This overlap is why a simple three-column comparison is a starting point rather than a complete treatment map. A drug may fit a mechanism-based category, and the overall plan may contain more than one treatment approach. When reviewing a recommendation, ask the clinician to name the specific treatment, explain its intended role, and describe how it relates to the other parts of the plan.
How clinicians decide which approach fits
There is no universal winner among chemotherapy, targeted therapy, and immunotherapy. Treatment decisions depend on the cancer type and how advanced it is, whether relevant biomarkers are present, the expected benefit in that situation, the possible side effects and monitoring, and the patient’s circumstances. A clinician may also consider whether treatments can be combined, what alternatives exist, or whether a clinical trial is relevant. NCI advises patients to discuss treatment choices with their care team.
For a useful conversation, work through the questions in context rather than asking which category is best in general:
- What cancer are we treating, and what is its stage or extent? The treatment purpose and available options can vary with these facts.
- Is biomarker testing relevant? Ask whether testing could identify a treatment-relevant feature, what a result would change, and whether any candidate treatment is actually available for that result.
- What benefit is expected for this situation? Ask what the proposed treatment is intended to do—cure, control, or ease symptoms, where applicable—and how the team will assess whether it is helping.
- What side effects and monitoring apply to this specific treatment? Ask which effects are expected, which symptoms require prompt attention, and whom to contact if they occur.
- Could treatments be combined, or are there alternatives? Ask why a single approach, a combination, a sequence, or another option is being considered, and whether a clinical trial is appropriate to discuss.
These questions do not replace a treatment recommendation. They help clarify how the clinician connects the cancer’s features and the patient’s needs to the proposed plan. For general treatment-choice information, see NCI’s Cancer Treatment overview.
A practical way to use the discussion is to compare the actual options on the same points: what each treatment is meant to do, what information supports considering it, what effects and monitoring are relevant, and whether it would be used alone or as part of a combination. If a biomarker test is proposed, ask what kinds of treatment decisions its result could inform and whether any possible result would change the options being discussed. The answer may be that testing is useful, or that it does not change the plan; either way, ask the clinician to explain the reasoning for this cancer.
Patient circumstances matter alongside the tumor information. The broad comparison cannot account for an individual’s health, treatment goals, or tolerance of possible effects. Tell the care team what matters most to you and ask how those concerns weigh against the expected benefit and monitoring needs of each specific option. A clear explanation should connect the proposed treatment to both the cancer and the person receiving it.
How to interpret a biomarker result
A biomarker report is one input to a decision, not a stand-alone answer to “which therapy will work?” Its practical meaning depends on the feature found, the cancer in which it was found, and whether there is a treatment option relevant to it. Even when a result points to a possible match, the tumor may not respond; tumor cells may differ from one another, and other features can influence the outcome.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
When reviewing testing with the oncology team, ask what the result means for the current cancer and whether it changes the options under consideration. If no matching treatment is available, or if the result does not establish likely benefit, the team will need to weigh other choices using the full clinical picture. NCI’s biomarker testing guide explains how testing can inform treatment without guaranteeing a response.
It is useful to separate three questions when reading a result: Was a feature detected? Is there a treatment that may act on that feature in this cancer context? Does the evidence and the patient’s situation make that treatment a reasonable option? The first answer does not automatically answer the second or third. Bring questions about the report to the oncology team rather than interpreting a biomarker name as a treatment instruction on its own.
Why side effects cannot be ranked by treatment category
The mechanisms suggest different ways healthy tissue can be affected: chemotherapy can harm healthy fast-growing cells, targeted therapies can produce effects such as diarrhea or liver problems depending on the drug, and immunotherapy can cause inflammation when immune activity affects healthy tissue. But that comparison does not establish that one type is generally safer. The possible effects, their seriousness, and the monitoring needed depend on the particular treatment and patient.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →For that reason, compare actual proposed treatments rather than broad labels. Ask for the treatment-specific side-effect information and a clear plan for what to do if symptoms arise. For immunotherapy in particular, effects can occur during treatment or later, so ask which symptoms require prompt attention and how to reach the care team. Do not assume that a treatment is low-risk simply because it is targeted, immune-based, or described as more precise.
Monitoring is also treatment-specific. The category tells you something about the intended mechanism, but not which checks, symptoms, or follow-up instructions apply to an individual regimen. Ask what the team will monitor and whom to contact with concerns. The goal is not to predict a person’s experience from a general list, but to know what applies to the treatment actually being considered.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Common misconceptions to avoid
- “Targeted” does not mean guaranteed to work. A target can make a treatment a possibility; it cannot promise benefit.
- “Targeted” does not mean side-effect free. Targeted therapies can have significant effects, and the profile varies by drug.
- “Immunotherapy” does not mean only cancer cells are affected. Immune activity can affect healthy tissues.
- “Chemotherapy versus targeted therapy versus immunotherapy” is not always an either-or choice. Treatments can be combined, and some therapies fit overlapping categories.
- A category-level comparison cannot determine the best plan. Cancer type, stage, biomarkers, patient factors, expected benefit, and treatment-specific effects all matter.
- A biomarker match is not a guarantee of benefit. Tumor cells may not all share the same biomarkers, other features can influence response, and a matching treatment may not be available.
- A possible combination is not automatically the right combination. Whether to combine or sequence treatments depends on the cancer and the role expected of each option.
Frequently asked questions
Is targeted therapy better than chemotherapy?
Not in every case. Targeted therapy acts on particular cancer-related targets or processes and often requires testing to see whether a relevant target is present. Chemotherapy acts on fast-growing cells and can be used to cure or control cancer or ease symptoms. Which is appropriate depends on the cancer, its extent, expected benefit, patient factors, and the specific treatment plan.
Does targeted therapy require biomarker testing?
In many cases, tumor testing helps determine whether a treatment-relevant target is present. Testing may also identify features that support considering certain immunotherapies. A result can point to a possible option, but it does not guarantee that the treatment will work or that a matching treatment is available.
Recommended Free Tools
Can targeted therapy and chemotherapy be used together?
They can be part of the same treatment plan. Chemotherapy may be combined with targeted therapy, immunotherapy, or other treatments, depending on the cancer and the plan’s goals. A clinician can explain why a combination or sequence is being considered for an individual case.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Is immunotherapy a type of targeted therapy?
Some treatments overlap categories. Many monoclonal antibodies are targeted cancer therapies, and some are also immunotherapy because they help turn the immune system against cancer. The labels describe mechanisms and are not always mutually exclusive.
Which treatment has fewer side effects?
There is no general answer based on category alone. Chemotherapy can affect healthy fast-growing cells; targeted therapy can cause effects such as diarrhea or liver problems depending on the drug; and immunotherapy can cause inflammation when immune activity affects healthy tissue. The specific treatment and patient determine the relevant risks and monitoring.
Can immunotherapy side effects happen after treatment?
Yes. NCI notes that immunotherapy side effects can occur during treatment or after it. Ask the care team which symptoms require prompt attention and how to report them for the specific therapy.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Frequently Asked Questions
Is targeted therapy better than chemotherapy?
Not in every case. Targeted therapy acts on particular cancer-related targets or processes and often requires testing to see whether a relevant target is present. Chemotherapy acts on fast-growing cells and can be used to cure or control cancer or ease symptoms. Which is appropriate depends on the cancer, its extent, expected benefit, patient factors, and the specific treatment plan.
Does targeted therapy require biomarker testing?
In many cases, tumor testing helps determine whether a treatment-relevant target is present. Testing may also identify features that support considering certain immunotherapies. A result can point to a possible option, but it does not guarantee that the treatment will work or that a matching treatment is available.
Can targeted therapy and chemotherapy be used together?
They can be part of the same treatment plan. Chemotherapy may be combined with targeted therapy, immunotherapy, or other treatments, depending on the cancer and the plan’s goals. A clinician can explain why a combination or sequence is being considered for an individual case.
Is immunotherapy a type of targeted therapy?
Some treatments overlap categories. Many monoclonal antibodies are targeted cancer therapies, and some are also immunotherapy because they help turn the immune system against cancer. The labels describe mechanisms and are not always mutually exclusive.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsWhich treatment has fewer side effects?
There is no general answer based on category alone. Chemotherapy can affect healthy fast-growing cells; targeted therapy can cause effects such as diarrhea or liver problems depending on the drug; and immunotherapy can cause inflammation when immune activity affects healthy tissue. The specific treatment and patient determine the relevant risks and monitoring.
Can immunotherapy side effects happen after treatment?
Yes. NCI notes that immunotherapy side effects can occur during treatment or after it. Ask the care team which symptoms require prompt attention and how to report them for the specific therapy.
The Bottom Line
Chemotherapy, targeted therapy, and immunotherapy work through different mechanisms, but none is universally best or safest. Biomarkers may help identify options, not promise a response; treatments can overlap or be combined, and side effects vary by treatment and patient. Ask your oncology team how each specific option fits your cancer, treatment goals, and health.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
